Effects of N-Methyl-D-aspartate (NMDA) antagonists ketamine, methoxetamine, and phencyclidine on the odor span test of working memory in rats
- PMID:29389166
- PMCID: PMC5797997
- DOI: 10.1037/pha0000158
Effects of N-Methyl-D-aspartate (NMDA) antagonists ketamine, methoxetamine, and phencyclidine on the odor span test of working memory in rats
Abstract
The glutamate hypothesis proposes that N-Methyl-D-aspartate (NMDA) receptor hypofunction underlies cognitive and perhaps other schizophrenic symptoms. The present study used the odor span task to assess the effects of NMDA antagonists on remembering multiple stimuli in rodents. This task uses an incrementing nonmatching-to-sample procedure in which responses to a new olfactory stimulus are reinforced on each trial, whereas responses to previously presented stimuli are not. NMDA antagonists have been associated with memory impairments in a variety of animal models; however, there are inconsistencies across different NMDA antagonists and tasks used. The current study compared the acute effects of phencyclidine (PCP), ketamine (KET), and the novel NMDA antagonist methoxetamine (MXE) on responding in the odor span task and a simple discrimination control task. PCP and MXE impaired odor span accuracy at doses that did not impair simple discrimination in most rats; however, the effects of KET were less selective. Within-session analyses indicated that the effects of PCP and MXE depended on the number of stimuli to remember, that is, impairment only occurred when the memory load was relatively high. These effects of PCP and MXE were consistent with the hypothesis that NMDA antagonists may interfere with working memory, but the basis for less selective results with KET are unclear. (PsycINFO Database Record
(c) 2018 APA, all rights reserved).
Conflict of interest statement
None of the authors report any conflict of interest relevant to the present research.
Figures









Similar articles
- Phencyclidine-like in vivo effects of methoxetamine in mice and rats.Berquist MD, Hyatt WS, Bauer-Erickson J, Gannon BM, Norwood AP, Fantegrossi WE.Berquist MD, et al.Neuropharmacology. 2018 May 15;134(Pt A):158-166. doi: 10.1016/j.neuropharm.2017.08.028. Epub 2017 Aug 19.Neuropharmacology. 2018.PMID:28830759Free PMC article.
- Effects of NMDA antagonist dizocilpine (MK-801) are modulated by the number of distractor stimuli in the rodent odor span task of working memory.Galizio M, Deal M, Mathews M, Panoz-Brown D, Prichard A, Bruce KE.Galizio M, et al.Neurobiol Learn Mem. 2019 May;161:51-56. doi: 10.1016/j.nlm.2019.03.004. Epub 2019 Mar 9.Neurobiol Learn Mem. 2019.PMID:30862525Free PMC article.
- The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.Halberstadt AL, Slepak N, Hyun J, Buell MR, Powell SB.Halberstadt AL, et al.Psychopharmacology (Berl). 2016 Apr;233(7):1215-25. doi: 10.1007/s00213-016-4203-3. Epub 2016 Jan 13.Psychopharmacology (Berl). 2016.PMID:26758284Free PMC article.
- Methoxetamine: A foe or friend?Botanas CJ, de la Peña JB, Kim HJ, Lee YS, Cheong JH.Botanas CJ, et al.Neurochem Int. 2019 Jan;122:1-7. doi: 10.1016/j.neuint.2018.10.020. Epub 2018 Oct 24.Neurochem Int. 2019.PMID:30365979Review.
- The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.Jentsch JD, Roth RH.Jentsch JD, et al.Neuropsychopharmacology. 1999 Mar;20(3):201-25. doi: 10.1016/S0893-133X(98)00060-8.Neuropsychopharmacology. 1999.PMID:10063482Review.
Cited by
- Olfactory Dysfunction in Schizophrenia: Evaluating Olfactory Abilities Across Species.Cothren TO, Evonko CJ, MacQueen DA.Cothren TO, et al.Curr Top Behav Neurosci. 2023;63:363-392. doi: 10.1007/7854_2022_390.Curr Top Behav Neurosci. 2023.PMID:36059004Review.
- Low-Dose Ketamine-Induced Deficits in Arbitrary Visuomotor Mapping in Monkeys.Zhao ZP, Nie C, Jiang CT, Cao SH, Tian KX, Han XY, Yu S, Gu JW.Zhao ZP, et al.eNeuro. 2023 Jun 27;10(6):ENEURO.0015-23.2023. doi: 10.1523/ENEURO.0015-23.2023. Print 2023 Jun.eNeuro. 2023.PMID:37336644Free PMC article.
- MiR-185-3p mimic promotes the chemosensitivity of CRC cells via AQP5.Zhou C, Kong W, Ju T, Xie Q, Zhai L.Zhou C, et al.Cancer Biol Ther. 2020 Sep 1;21(9):790-798. doi: 10.1080/15384047.2020.1761238. Epub 2020 Jun 26.Cancer Biol Ther. 2020.PMID:32588739Free PMC article.
- Circular RNA circHIPK3 promotes breast cancer progression via sponging MiR-326.Luo N, Liu S, Li X, Hu Y, Zhang K.Luo N, et al.Cell Cycle. 2021 Jul;20(13):1320-1333. doi: 10.1080/15384101.2021.1939476. Epub 2021 Jun 21.Cell Cycle. 2021.PMID:34152928Free PMC article.
- Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix.Cui L, Jiang X, Zhang C, Li D, Yu S, Wan F, Ma Y, Guo W, Shan Z.Cui L, et al.Biosci Rep. 2019 Oct 30;39(10):BSR20190595. doi: 10.1042/BSR20190595.Biosci Rep. 2019.PMID:31652453Free PMC article.
References
- Bannerman DM, Rawlins JNP, Good MA. The drugs don’t work—or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A- containing AMPA receptors to hippocampal-dependent memory. Psychopharmacology. 2006;188:552–566. - PubMed
- Chiamulera C, Armani F, Mutti A, Fattore L. The ketamine analogue MXE generalizes to ketamine discriminative stimulus in rats. Behavioural Pharmacology. 2016;27:204–210. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources